glp-1 long term safety Medications: Everything You Need to Know Long-Term Effects Of GLP-1s: Risks

Mangmool S, Hemplueksa P, Parichatikanond W, Chattipakorn N

Weekly or bi-weekly for active protocols

#glutathione #learnontiktok #healthtok #pharmacy #farmasi Ramai DM tanya saya, kalau dah beli ASGG GlutaGenC Glow Gummies atau produk glutathione collagen, selamat ke nak makan

Introduction BPC-157 is provided as a nasal solution with a concentration of 0.5mg per 30mL vial, formulated exclusively for research use only (RUO)

Managing gallstone risk on Mounjaro Optimal weight loss rate The key to minimising gallstone risk is controlling your weight loss rate: Recommended targets: Week 1-4: 0.5-1 kg per week Week 5-12: 0.5-1 kg per week After 12 weeks: 0.5-1 kg per week Maximum safe rate: 1 kg per week Strategies to control weight loss rate: Start with the lowest dose (2.5 mg) Delay dose escalation if losing too quickly Ensure adequate calorie intake (maximum 10% deficit) Add protein-rich snacks if weight loss exceeds 1 kg/week Dietary strategies Specific dietary approaches can reduce gallstone risk during weight loss: Eat a diet based mainly on whole foods: Healthy fats: Include a portion the size of your thumb in each meal from nuts, meat, fish, olive oil, and dairy Fibre: Aim for half of your plate to come from vegetables Protein: Aim for a portion the size of an open hand in each meal Foods to moderate: Refined sugars and ultra-processed foods Take-aways Very low-fat diets ( 5 hours Fever with abdominal pain Yellowing of skin or eyes (jaundice) Dark urine and pale stools Medical monitoring requirements Baseline assessments Before starting Mounjaro with known gallstones: Essential tests: Complete medical history, including gallstone symptoms Physical examination Baseline weight and BMI Liver function tests (ALT, AST, ALP, bilirubin) Consider if indicated: Abdominal ultrasound if symptoms present Lipid profile Inflammatory markers if previous cholecystitis Follow-up schedule The following monitoring schedule represents expert practice suggestions rather than a fixed protocol: When to pause treatment Consider temporarily stopping Mounjaro if: Biliary colic episodes occur Liver function tests become abnormal Weight loss exceeds 2 kg per week consistently Severe gastrointestinal symptoms develop Pending gallbladder surgery Alternative weight loss options Other GLP-1 medications Different GLP-1 medications may have varying gallbladder risk profiles

The treated cells retained structural integrity, with MSNs-ss-SA primarily localized in vacuoles (VAC), cell walls (CW), and chloroplasts (Chl)